Tvardi Therapeutics, Inc. (TVRD) stock
TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04+0.03 (+2.97%)
Close on Nov 18, 2026Market cap $13.87MP/E –Yield 0.00%
Tvardi Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Tvardi Therapeutics's pe ratio was 70.9× on Jan 31, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jan 31, 2022 | 70.9× | −3.7 |
| 2021 | Dec 31, 2021 | 74.6× | – |
See a number that looks wrong?